NEW YORK (GenomeWeb) – Trinian announced today that the European Molecular Genetics Quality Network (EMQN) is now using the firm's DropSense 96 micro-volume spectrophotometry technology as part of its quality control assessments.
EMQN has adopted the Trinean DropSense 96 reader and cDrop purity analysis software for the quality control of all DNA material used in EMQN's External Quality Assessment program, which allows diagnostic labs to benchmark and improve laboratory performance. EQA procedures are designed to test a clinical laboratory's whole analytical process, its ability to interpret data in the light of clinical information supplied with a referral, and its ability to produce a clear and accurate report.
"The integration of the DropSense 96 reader has significantly improved our QC processes enabling us to rapidly assess the quality of our EQA materials," EMQN Director Simon Patton said in a statement. "We look forward to working with Trinean as we further integrate its technology in to our activities."
Gentbrugge, Belgium-based Trinian is a spinout of Ghent University and Imec Leuven.
In December 2015, EMQN formed a strategic partnership with Euformatics and the UK National External Quality Assessment Service for Molecular Genetics to automate data validity checks and enhance the NGS EQA result assessment processes to include more quality metric measures for laboratories.